Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.32 USD
0.67%
Market Closed
Updated:
May 10, 2024
Prestige Consumer Healthcare Inc
Capital Expenditures
|
Prestige Consumer Healthcare Inc
Capital Expenditures Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Capital Expenditures
-$9m
|
CAGR 3-Years
29%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-8%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Capital Expenditures
-$4.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Capital Expenditures
-$1.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
|
Pfizer Inc
NYSE:PFE
|
Capital Expenditures
-$3.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Capital Expenditures
-$3.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Capital Expenditures
-$7.6B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-21%
|
See Also
What is Prestige Consumer Healthcare Inc's Capital Expenditures?
Capital Expenditures
-9m
USD
-9m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Capital Expenditures amounts to -9m USD.
What is Prestige Consumer Healthcare Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%
-8%
Over the last year, the Capital Expenditures growth was -7%. The average annual Capital Expenditures growth rates for Prestige Consumer Healthcare Inc have been 29% over the past three years , 2% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
